Transaction #22828 · Form 4 · 0001193125-26-424428
Xenon Pharmaceuticals Inc. · Exercise / conversion · Common Shares
Xenon Pharmaceuticals Inc. · Transacted October 15, 2026 · Filed October 16, 2026
What does this filing report?
An SEC Form 4 filing for Xenon Pharmaceuticals Inc. records an exercise / conversion involving Common Shares on October 15, 2026. The reported quantity was 7,500. The filing date is October 16, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Xenon Pharmaceuticals Inc.
- Company CIK
- 0001582313
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 7,500
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 22,500
- Ownership description
- Not reported
- SEC acceptance time
- Oct 16, 2026, 8:22 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Kelly Thomas Patrick ↗
Chief Financial Officer
CIK 0001410514
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on October 15, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on October 15, 2026.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.